Bacterial colicin-immunity protein protein purification system
US-2024417426-A1 · Dec 19, 2024 · US
US9394561B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9394561-B2 |
| Application number | US-201214363561-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 7, 2012 |
| Priority date | Dec 7, 2011 |
| Publication date | Jul 19, 2016 |
| Grant date | Jul 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An enzyme useful for producing cyclic peptides from linear peptide precursors and a gene encoding the enzyme are described. The enzyme is particularly useful for producing segetalins from linear presegetalin precursors. The linear presegetalin precursors may be derived from other linear presegetalin precursors farther upstream in the biosynthetic synthesis of the segetalin.
Opening claim text (preview).
The invention claimed is: 1. An recombinant polypeptide comprising an amino acid sequence having at least 95% sequence identity to the amino acid sequence as set forth in SEQ ID NO: 2 and has a function of peptide cyclization, wherein the recombinant polypeptide is recombinantly expressed in a microorganism. 2. The recombinant polypeptide according to claim 1 , wherein the amino acid sequence has at least 99% sequence identity to the amino acid sequence as set forth in SEQ ID NO: 2. 3. The recombinant polypeptide according to claim 1 , wherein the amino acid sequence is as set forth in SEQ ID NO: 2. 4. A process of producing a cyclic peptide, the process comprising contacting a suitable linear peptide precursor of the cyclic peptide with the polypeptide of claim 1 to produce the cyclic peptide from the linear peptide precursor. 5. The process according to claim 1 , wherein the amino acid sequence is as set forth in SEQ ID NO: 2. 6. The process according to claim 4 , wherein the linear peptide precursor is provided to a microbial host cell transformed or transfected with a nucleic acid molecule encoding the recombinant polypeptide according to claim 1 . 7. The process according to claim 4 , wherein the cyclic peptide is segetalin A. 8. The process according to claim 4 , wherein the cyclic peptide comprises the amino acid sequence as set forth in SEQ ID NO: 77. 9. The process according to claim 4 , wherein the linear peptide precursor is produced by a recombinant organism.
produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00) · CPC title
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title
Cyclic peptides containing only normal peptide links · CPC title
acting on peptide bonds (3.4) · CPC title
for the production of primary gene products, e.g. pharmaceutical products, interferon · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.